Sara K Silbert

Trials

Studies that name Sara K Silbert as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:34 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT07328503 · CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

  National Cancer Institute (NCI) · recruiting · Acute Lymphoblastic Leukemia, B-All · principal investigator
• N/A
  NCT05969002 · Pilot Prospective Study for PET-CT Imaging in Participants With Relapsed/Refractory Acute Leukemias

  National Cancer Institute (NCI) · completed · B Cell, Acute Lymphoblastic Leukemia, Relapsed/Refractory · principal investigator
• Ph1/Ph2
  NCT05442515 · CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies

  National Cancer Institute (NCI) · recruiting · B-NHL, B-Non Hodgkin Lymphoma, Acute Lymphocytic Leukemia · principal investigator
• N/A
  NCT05440409 · CAR-Multicenter Analysis (CAR-MA): Retrospective Study to Characterize CAR T-cell Outcomes and Related Toxicities in Children and Young Adults With B-ALL

  National Cancer Institute (NCI) · completed · Leukemia, Acute Lymphoblastic, Lymphoblastic Leukemia, Acute, Childhood · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 00:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.